Skip to main content

Premature Labor News (Page 4)

FDA Medwatch Alert: Magnesium Sulfate: Drug Safety Communication - Recommendation Against Prolonged Use in Pre-term Labor

ISSUE: FDA is advising health care professionals against using magnesium sulfate injection for more than 5-7 days to stop pre-term labor in pregnant women. Administration of magnesium sulfate...

FDA Approves Makena to Reduce Risk of Preterm Birth in At-Risk Pregnant Women

SILVER SPRING, Md., Feb. 4, 2011 /PRNewswire-USNewswire/ – The U.S. Food and Drug Administration today approved Makena (hydroxyprogesterone caproate) injection to reduce the risk of preterm delivery...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related drug support groups

progesterone, nifedipine